Sandoz’s High-Concentration Humira Biosimilar Lands On FDA’s Desk

SBLA Follows EMA Accepting Proposed Biosimilar For Filing In June

 
• By Dean Rudge
  
FDA website
Sandoz's filing is now with both the US and EU regulators • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products